Durata Defibrillation Leads
ABBOTT MEDICAL · Decision date Nov 20, 2025
What did the FDA approve?
FDA records P950022/S150 as a supplement to PMA P950022, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Nov 20, 2025.
FDA approval order statement
approval for model line extensions for the Zenex MRI & Zenus MRI families of pacemakers and updated labeling for cardiac leads and additional pacemaker models
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 20, 2025
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P950022/S150
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- LWS
- Decision code
- APPR
- Decision date
- Nov 20, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable cardioverter defibrillator (non-CRT).
- Applicant
- Abbott Medical
- Product code
- LWS
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P950022. Subsequent supplements may change the device or its indications.
FDA decision timeline
P950022 · Original PMA
TVL(TM) LEAD SYSTEM
P950022/S150 received
Application receipt date recorded by FDA.
P950022/S150 · FDA decision
Normal 180 Day Track
P950022/S151 · Related supplement
Durata Leads; Optisure Leads
P950022/S148 · Related supplement
Durata, Optisure
P950022/S152 · Related supplement
Durata Leads (7120, 7121, 7122, 7120Q, 7121Q, 7122Q, 7170, 7170Q, 7172Q, 7171Q)
P950022/S154 · Related supplement
Durata Leads; Optisure Leads; UltiSync Leads
P950022/S153 · Related supplement
UltiSynq Defibrillation lead; SurGrip Suture Sleeve Accessory
Timeline entries are records held by MedtechLedger for P950022. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P950022
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
TVL(TM) LEAD SYSTEMP950022 | ABBOTT MEDICAL | PMA approval | May 10, 1996 | FDA |
Durata Leads; Optisure LeadsP950022/S151 | ABBOTT MEDICAL | PMA supplement | Dec 9, 2025 | FDA |
Durata, OptisureP950022/S148 | ABBOTT MEDICAL | PMA supplement | Feb 19, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Apr 24, 2026 | FDA | |
Durata Leads; Optisure Leads; UltiSync LeadsP950022/S154 | ABBOTT MEDICAL | PMA supplement | Jun 26, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Nov 5, 2026 | FDA |
Explore the linked device profile
Other records with product code LWS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Nov 4, 2026 | FDA | |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S967 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 29, 2026 | FDA |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 9, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 15900 Valley View Ct., Sylmar, CA, 91335
Sources and methodology
- Original FDA record: P950022/S150
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





